Hyun-Ju Kim
Radiation Oncology Hyun-Ju Kim Favorite Doctor
  • SpecialtyGynecologic cancer, Genitourinary cancer, Head/Neck cancer, Hepatobiliary cancer, Pancreatic cancer, Pediatric cancer, Palliative radiotherapy
  • Site
의료진 진료일정
Week M T W T F S
AM   Present        
PM     Present Present    
Clinical Interests

Gynecologic cancer
Genitourinary cancer
Head/Neck cancer
Hepatobiliary cancer
Pancreatic cancer
Pediatric cancer
Palliative radiotherapy

2012 Yonsei University College of Medicine, M.D.
Present Department of Radiation Oncology, Gachon University Gil Medical Center, Assistant Professor
2019 Department of Radiation Oncology, Gachon University Gil Medical Center, Clinical Assistant Professor
2018 Department of Radiation Oncology, Gachon University Gil Medical Center, Clinical Instructor
2017 Department of Radiation Oncology, Severance Hospital of Yonsei University, Clinical Instructor
2013 Department of Radiation Oncology, Severance Hospital of Yonsei University, Resident
2012 Severance Hospital of Yonsei University, Intern
2016 Short-term training in Nejmehen University Hospital, Netherlands
2017 Radiation Oncology Specialist
2012 Medical License
Hyun-Ju Kim
2019 Kim HJ, Chang JS, Roh MR, Oh BH, Chung K-Y, Shin SJ, Koom WS. Effect of Radiotherapy Combined With Pembrolizumab on Local Tumor Control in Mucosal Melanoma Patients. Front Oncol. 2019 Sep;9:835.
2019 Rim CH, Kim HJ, Seong J. Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. Radiother Oncol. 2019 Feb;131:135-144.
2019 Kim KB, Shin KH, Kim JH, Choi DH, Park W, Kim YB, Kim HJ, Kim JH, Park H, Lee SY, Kim J, Oh DH, Kim IA. Central Nervous System Failure in Korean Breast Cancer Patients with HER2-Enriched Subtype: Korean Radiation Oncology Group 16-15 Multicenter Retrospective Study. J Breast Cancer. 2019 Mar;22(1):e1.
2019 Yang A, Choi SH, Byun HK, Kim HJ, Choi J, Lee YC, Lee SK, Park KR, Lee CG. Management of Clinical T1N0M0 Esophageal Cancer. Gut and Liver. 2019 May;13(3):315-324.
2019 Kim N, Kim HJ, Won JY, Kim DY, Han KH, Jung I, Seong J. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma. Radiother Oncol. 2019;131:81-87.
2019 Byun HK, Kim HJ, Im YR, Kim DY, Han KH, Seong J. Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma. Radiother Oncol. 2019;133:1-8.
2018 "Kim HJ, Koom WS, Cho J, Kim HS, Suh CO. Efficacy of Postoperative Radiotherapy Using Modern Techniques in Patients with Retroperitoneal Soft Tissue Sarcoma. Yonsei Med J. 2018 Nov;59(9):1049-1056.
2018 " Kim HJ, Park S, Kim KJ, Seong J. Clinical significance of soluble programmed cell death ligand-1 (sPD-L1) in hepatocellular carcinoma patients treated with radiotherapy. Radiother Oncol. 2018 Oct;129:130-135.
2018 Kim HJ, Chang JS, Koom WS, Lee KC, Kim GE, Kim YB. Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer. Gynecol Oncol. 2018 Sep;151:208-214.
2017 "Byun HK, Yoon HI, Cho J, Kim HJ, Min YH, Lyu CJ, Cheong JW, Kim JS, Kim HS, Kim SJ, Yang AJ, Lee BM, Lee WH, Lee J, Ahn KJ, Suh CO. Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation. Radiat Oncol J. 2017 Sep;35(3):257-267.
2017 " "Kim HJ, Suh YG, Lee YC, Lee SK, Shin SK, Cho BC, Lee CG. Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy. Cancer Res Treat. 2017 Jul;49(3):669-677.
2016 " Kim HJ, Lee WJ, Kang CM, Hwang HK, Bang SM, Song SY, Seong J. Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer. PLoS One. 2016 Jun 22;11(6):e0157196.
2016 Suh YG, Lee CG, Kim HJ, Choi EC, Kim SH, Kim CH, Keum KC. Treatment outcomes of intensity-modulated radiotherapy versus 3D conformal radiotherapy for patients with maxillary sinus cancer in the postoperative setting. Head Neck. 2016 Apr;38 Suppl 1:E207-13.
2015 Choi C, Park JH, Lee CG, Kim HJ, Suh CO, Cho J. Successful salvage treatment of myxoid liposarcoma with multiple peritoneal seeding using helical tomotherapy-based intraperitoneal radiotherapy: a case report. BMC Res Notes. 2015 May 2;8:179.
2015 Kim HJ, Rhee WJ, Choi SH, Nam EJ, Kim SW, Kim S, Kim YT, Kim GE, Kim YB. Clinical outcomes of adjuvant radiation therapy and prognostic factors in early stage uterine cervical cancer. Radiat Oncol J. 2015 Jun;33(2):126-33.
2014 Rhee WJ, Kim KH, Chang JS, Kim HJ, Choi S, Koom WS. Vertebral compression fractures after spine irradiation using conventional fractionation in patients with metastatic colorectal cancer. Radiat Oncol J. 2014 Dec;32(4):221-30.
2013 Kim MS, Keum KC, Rhee WJ, Kim HJ, Kim M, Choi S, Nam KC, Koom WS. The location of locoregional recurrence in pathologic T3N0, non-irradiated lower rectal cancer. Radiat Oncol J. 2013 Jun;31(2):97-103.